Icon

ABLAVAR (nda021711)- (2440MG/10ML (244MG/ML),3660MG/15ML (244MG/ML))

GADOFOSVESET TRISODIUM LANTHEUS MEDCL
2440MG/10ML (244MG/ML),3660MG/15ML (244MG/ML)
No No
2020-May-04 2013-Dec-22
None None
None No
ABLAVAR Injection is a gadolinium-based contrast agent indicated for use as a contrast agent in magnetic resonance angiography (MRA) to evaluate aortoiliac occlusive disease (AIOD) in adults with known or suspected peripheral vascular disease.
0 0 0
Total Other Developers None
Drugs with Suitability No
2440MG/10ML (244MG/ML) ** ** - - -
3660MG/15ML (244MG/ML) ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.